HDL cholesterol efflux capacity and lipid profile in patients with systemic sclerosis

OBJECTIVE: It is well established that patients with systemic sclerosis (SSc) have a disrupted lipid profile and an increased cardiovascular risk. Cholesterol efflux capacity (CEC), the ability of high-density lipoprotein (HDL)-cholesterol to accept cholesterol from macrophages, has been linked to c...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Arthritis Res Ther
Autors principals: Ferraz-Amaro, Iván, Delgado-Frías, Esmeralda, Hernández-Hernández, Vanesa, Sánchez-Pérez, Hiurma, de Armas-Rillo, Laura, Armas-González, Estefanía, Machado, José David, Diaz-González, Federico
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2021
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7901093/
https://ncbi.nlm.nih.gov/pubmed/33622410
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-021-02443-9
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars